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ABSTRACT
New diagnostic approaches to monitor irrigating fluid absorption
Rinsing the endoscopic operating field with an irrigating solution entails the risk 
of absorption of the fluid. The physiological consequences of such absorption 
are explored and two new methods for monitoring the amount of absorption are 
proposed.
Methods: Paper 1: 25 anesthetized pigs were randomized to control or  continuous 
infusion of 100 ml/kg over 90 min of either glycine 1.5%, mannitol 3% or mannitol 
5%. Several invasive measurements and calculations were performed to describe the 
pathophysiological processes. Paper 2: Exhaled air nitrous oxide (N2O) concentra­
tions were measured in 12 volunteers receiving intravenous infusions, containing 
dissolved nitrous oxide and simulating fluid absorption. Paper 3: Comparison of 
N2O and ethanol for detecting absorption in 86 patients, at 2 centres, undergoing 
transurethral resection of the prostate (TURP) in spinal anesthesia. Paper 4: A 3­part 
evaluation of glucose as a tracer in fluid absorption detection. Part 1 was a clini­
cal study in 250 patients undergoing TURP with and without a glucose­containing 
irrigant. Part 2 investigated the glucose kinetics in 10 volunteers receiving 20 ml/kg 
of acetated Ringer's solution with 1% glucose over 30 min. In part 3, data was used 
for computer simulations of various absorption patterns.
Results: (Paper 1): Infusions rendered a hypokinetic hypotensive state. Intracellular 
volume expansion, intracranial pressure elevation and myocardial damage were 
greater for glycine 1.5%. (Paper 2): N2O is a useful tracer for noninvasive fluid 
absorption monitoring. It identifies the pattern and the volume of absorption with 
a 95% predicition interval of ± 200 ml. (Paper 3): The N2O method is feasible in 
a clinical setting. Agreement with the ethanol method was volume dependent and 
about twice that of N2O versus known volume. (Paper 4): Sodium and glucose 
showed a strong inverse linear relation for all patients including diabetics. The 
glucose levels almost doubled after the experimental infusions, which volume 
diluted the plasma by 17.7%. Simulations showed that the infused volume cor­
related with the rise in glucose where an increase by more than 1.4 mmol/L could 
detect absorption with 95% confidence.
Conclusion: The pathophysiological process and treatment rationale of massive 
nonelectrolytic irrigating fluid absorption was outlined. The N2O method allows 
noninvasive online monitoring of irrigating fluid absorption with better resolu­
tion and similar or better prediction of absorbed volume compared to the ethanol 
method. Glucose can be used as a tracer for retrospective evaluation of irrigating 
fluid absorption. 
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LIST OF ABBREVIATIONS
AUC Area under the curve
BW Body weight
CL Clearance
CO Cardiac output
CO2 Carbon dioxide
ECF Extracellular fluid
GCP Good clinical practice
Glc Glucose
GFR Glomerular filtration rate
Hct Hematocrit
Hgb Blood hemogobin
HR Heart rate
ICP Intracranial pressure
ICV Intracellular (fluid) volume
IV Intravenous
Kb Basal diuresis and evaporation
Ki Infusion rate constant
kPa Kilo Pascal
Kr Elimination rate constant
Kt Distribution rate constant
L Litres
MCV Mean corpuscular cell volume
Min Minutes
Ml Millilitres = 0,001 liter
Mmol Millimoles
N20 Nitrous oxide
NS Isotonic (Normal) saline
OEL:s Occupational exposure limits
RBC Red blood cell count
RS Lactated or acetated Ringer’s solution
SD Standard deviation
Sec Seconds
SEM Standard error of the mean
TBW Total body water
TCRE Transcervical endometrial resection
TUR syndrome Transurethral resection syndrome
TURP Transurethral resection of the prostate
V Expanded body fluid volume
V Not expanded body fluid volume
Vd The volume of distribution
w/v Weight per volume
11 THESIS AT A GLANCE
Paper Aim Method Main result
I. High-dose 
Intravenous Infusion 
of Irrigating Fluids 
Containing Glycine 
and Mannitol in 
the Pig
To describe the 
 pathophysiological 
process and 
 compartmental 
 distribution of 
 excessive  absorption 
of two common 
 irrigating solutions
25 anesthetized pigs 
randomized to control or 
continuous infusion of 
100 ml/kg over 90 min 
of either glycine 1.5%, 
mannitol 3 or 5%
Both infusions rendered 
a hypokinetic hypotensive 
state. Intracellular volume 
expansion, elevation of 
intracranial pressure and 
myocardial damage were 
greater for glycine 1,5%.
II. Nitrous oxide 
for monitoring fluid 
absorption in 
volunteers
To investigate if N2O 
can be used as a 
tracer in  irrigating 
solutions and thus 
allowing online 
monitoring of fluid 
absorption
Measurements of N2O 
and CO2 in exhaled air 
during normal  breathing 
in 12 volunteers  receiving 
iv infusions,  containing 
dissolved N2O and 
 mimicking fluid absorption 
N2O is a useful tracer for 
noninvasive  monitoring 
of fluid absorption. It 
distinguishes different 
absorption patterns and 
precisely predicts the 
total volume absorbed.
III. Monitoring of 
fluid  absorption 
with nitrous oxide 
 during transurethral 
 resection of the 
prostate
To compare ethanol 
and N2O as tracers 
for online  monitoring 
of irrigating fluid 
absorption in a 
 clinical setting 
GCP protocolized 
2 center study in 
86 patients  undergoing 
TURP in spinal 
anaesthesia
N2O can be used as a 
tracer for fluid  absorption 
in a clinical setting. 
Agreement with the 
 ethanol method was 
volume dependant and 
about twice that of N2O 
vs known volume.
IV. Glucose as a 
marker of fluid 
absorption in bipolar 
transurethral surgery
To evalute if glucose 
can be used as a 
tracer for retrospect 
analysis of volume 
of irrigating fluid 
absorption when 
sodium dilution is not 
possible, i.e. during 
bipolar TURP 
Study comprising three 
parts: 1) A clinical study 
on 250 patients under-
going TURP with electro-
lyte free irrigant and 
randomized to either con-
tain 5% glucose or no glu-
cose. 2) An experimental 
part on glucose kinetics 
in 10 volunteers receiv-
ing a 30 min iv infusion of 
20 ml/kg of R-Ac with 1% 
glucose. 3) A computer 
simulation study on vari-
ous absorption patterns
Sodium and  glucose 
showed a strong 
inverse linear relation 
for all patients including 
 diabetics. The glucose 
levels almost doubled 
after the experimental 
infusions and yielded 
a 17.7% plasma dilution. 
Simulations showed a 
 volume correlated rise 
in glucose where an 
increase by more than 
1.4 mmol/L detected 
absorption with 95% 
confidence
22 SUMMARY IN SWEDISH  
(SAMMANFATTNING PÅ SVENSKA)
Vid titthålskirurgi, så kallad endoskopi, används ofta spolvätskor för att vidga och skölja 
rent operationsfältet. I kontakt med kroppens vävnader finns det då risk att vätskan 
absorberas d.v.s. tas upp i kroppen. Vid skrapning av prostatan eller liv modern är det 
vanligt att 9 respektive 15 liter spolvätska används. Om ojordad elektrisk bränning 
används måste spolvätskan vara saltfri då den annars kan leda ström och explosioner 
kan uppstå. Nyare operationsmetoder använder jordad bränningsteknik vilket gör att 
vanligt koksalt då kan användas. Absorption över 3 liter, vilket sker vid upp till 10 av 
100 operationer, kan orsaka livshotande tillstånd till följd av akut övervätskning och 
rubbad saltbalans. Befintliga sätt att mäta graden av absorption är mer eller mindre 
krångliga och tillförlitliga och används i liten grad. Alkohol kan tillsättas till spolvätskan 
och koncentrationen i utandningsluften återspeglar då hur stor volym patienten fått i 
sig. Nackdelar med metoden är att alkohol  försvinner långsamt ur kroppen samt att 
det vid stor absorption kan ge lättare berusning.
Den här avhandlingen består av 4 delarbeten. I arbete 1 studerade vi effekterna av 
massiv absorption av de saltfria spolvätskorna glycin och mannitol på 25 grisar. 
Resultaten visade att spolvätskorna ger kraftig urinproduktion med uttorkning och 
kraftigt  försämrad cirkulation som följd. Dessutom sågs glycin ge större cellsvullnad, 
högre tryck i hjärnan och mer skada på hjärtat. I delarbete 2 testade vi om lustgas kan 
användas för att diagnostisera spolvätskeabsorption. Vi löste en liten mängd lustgas 
(slutkoncentration 40 ml/L) i spolvätskan och testade olika tillförseltakter och mät­
metoder på 12 försökspersoner. Lustgasmängderna som togs upp i  kroppen svarade 
mot absorptionsmängden och kunde passivt mätas i utandningsluften med hjälp av en 
syrgasgrimma och en lustgasmätare. Utandningsmönstret visade både den absorberade 
mängden och om det skett direkt in i blodbanan eller via ansamling i när liggande hål­
rum. I arbete 3 jämförde vi lustgas och etanolmetoderna på 86 patienter som genomgick 
skrapning av prostatan. Båda metoderna fungerade bra men stämde inte lika bra överens 
som då jämförelse gjordes med den kända vätske mängden i arbete 2. Korrelationen 
varierade med graden av absorption. I arbete 4 utvärderade vi om socker kan tillsättas 
till spolvätskan för att i efterhand värdera graden av absorption. När saltinnehållande 
spolvätska används kan inte mätning av salthalten i blodet användas för att värdera om 
absorption skett. Först studerade vi 250 patienter som lottats till att få sockerhaltig eller 
sockerfri saltfri spolvätska vid prostataskrapning. Vid absorption av sockerhaltig saltfri 
spolvätska visade blodprover att blodsockerstegringen svarade mot utspädningen av 
salt i blodet. Detta stämde även för diabetiker då blodsockernivåerna under operation 
beror mer på hur tillförda mängder socker omfördelas i kroppen än på insulineffekter. 
Därefter studerade vi omfördelningen av en 1%­ig sockerlösning i kroppen hos 10 
försökspersoner. De erhållna värdena användes i simuleringar av olika vätskemängder 
och vi såg att ökningen av blodsockret svarade mot absorptionsmängden. 
Sammanfattningsvis visar den här avhandlingen mekanismerna bakom skadorna vid 
saltfri spolvätskeabsorption och visar 2 nya metoder som kan användas för mätning 
av spolvätskeupptag.
33 GENERAL INTRODUCTION
Endoscopic surgery with the use of irrigating fluids to expand and rinse the operat­
ing field has been performed for nearly a century now. Immediate complications 
include blood loss and the absorption of the irrigating solution. Although several 
advances have been made as to the understanding of the pathophysiological mecha­
nisms and operating and monitoring methods, there is still an unjustified sense 
of misunderstanding regarding the risks of absorption. The medical community’s 
perception that adverse reactions are rare and generally avoidable is misleading. 
Numerous case reports can witness to this. Historically, only electrolyte­free irri­
gating solutions were used in order to prevent dispersion of the current during 
electrocautery, but new operating techniques have allowed, since two decades, for 
the introduction of electrolyte­containing irrigants. These solutions have indeed 
made absorption less hazardous but complications of fluid overload are still 
important patient safety issues. Administration of fluids is well known to require 
conscious strategies and does not allow for unintentional deviation which is the 
case when the risks of absorption are unaccounted for. This thesis explores the 
gradual pathophysiologic effects in massive nonelectrolytic irrigating fluid absorp­
tion and proposes new diagnostical approaches in monitoring techniques for such 
events. We investigated the usefulness and feasibility of adding nitrous oxide or 
glucose as a tracer to the irrigating solutions and thereby allowing sampling of 
these substances for the detection of absorption.
44 THE USE OF IRRIGATING FLUIDS
4.1 Purpose and Introduction
Irrigating fluids are used in endoscopic surgery to distend the operating area or 
anatomical space and to rinse the surgical field from blood and debris. Examples 
of such use is in arthroscopy, liposuction, rinsing of the urinary bladder, lithotripsy, 
lithotomy, transurethral vaporization of the prostate, transcervical endometrial 
resection (TCRE) and transurethral resection of the prostate (TURP). Amounts of 
irrigant being used varies with the type of procedure and the length of the opera­
tion. Volumes can be quite large and averages 15 litres (L) during a 45­minute 
long TURP and 9 L in TCRE [1­4]. Variations in average volumes used may  differ 
significantly between various types of surgery and cohorts, ranging from 2 L to 
more than tenfold that [1­6]. In a single procedure, the amount can occasionally 
be around threefold the average. Nearly all of this fluid is directly recovered from 
the operating field but in the contact with human tissue there is a risk that it is 
partly absorbed.
Absorption can occur via two routes. Severing of veins, in TURP and TCRE, causes 
the more commonly seen intravascular absorption which then usually starts halfway 
into the surgery or later and continues until the end of the operation [7­11]. The 
pattern of absorption resembles an intermittent intravenous infusion since fluid is 
driven into the damaged vein every time the irrigating solution pressure exceeds 
the venous pressure of 1.5 kPa [12]. Absorption via the extravascular route origi­
nates from passage through the fallopian tubes or instrumental perforation of the 
endometrial wall, urinary bladder or prostatic capsule [11, 13­14]. The absorp­
tion pattern then looks like a continuous intravenous infusion since the pressure 
of the irrigant only needs to exceed the intra­abdominal pressure of 0.5 kPa [15].
Main questions to be addressed when choosing an irrigating solution are the sur­
gical needs and the risks of absorption. The latter includes issues regarding the 
solution specific attributable effects of absorption, how the risks of absorption 
are assessed and how this is monitored in relation to the timing of what adequate 
actions should be undertaken.
4.2 Irrigating solutions
Irrigating solutions are used in large quantities. They should allow optimal visu­
alization and not cause additional patient risks. Thus the ideal solution should be 
sterile, clear, relatively inexpensive, as well as locally and systemically nontoxic. 
Absorption of water gives hemolysis with subsequent kidney damage due to hemo­
globinuria which causes vasoconstriction with hypoxic cellular damage known 
as lower nephron nephrosis. Isotonic and non­hemolytic irrigating fluids, as pro­
posed by Creevy, Nesbit and Glickman already 70 years ago, are thus preferable if 
5absorption occurs [16, 17]. Electrically conductive solutions, such as saline, cannot 
be used if monopolar cautery is needed. This led to the development of the non­
conductive and non­hemolytic irrigants glycine, mannitol and sorbitol [17­20]. In 
the beginning of the 21:st century, the development of bipolar resectoscopes made 
it possible to irrigate the surgical field with conductive solutions. Isotonic saline 
(NS) is the most widely used solution for this purpose although Ringer’s solution 
(RS) seems to give similar visibility for the surgeon and less adverse effects if 
absorption occurs [21­24]. An overview of available irrigating fluids and some of 
their properties is listed in table 1 below.
Table 1. Specific properties and side effects of available irrigating solutions. 
All irrigating solutions cause volume effects if absorbed. Glucose 2.5%-4% 
and urea 1% are not listed in the table since they cause stickiness respectively 
crystallization on the instruments and are hence not widely used. The half-life 
of glycine and sorbitol increase with the dose. 
Sterile water Glycine 1.5% Mannitol 5% Sorbitol 3% Normal 
saline
Ringer's 
lactate
Osmolality 
(mosm/L)
0 220 275 165 308 273
Volume of  
distribution (L)
42 (TBW) 20 40 23 8.2* 8.1*
Main elimination 
site
Kidney Liver Kidney Liver Kidney Kidney
Metabolites None Ammonia None fructose, 
 glycogen, CO2
None None
Half-life (min) 40 100 30 110* 50*
Additional available 
irrigating solution 
preparations
- 1.2%, 2.2% 3% sorbitol and 
 mannitol mixtures: 
2% + 1%, 2.7% 
+ 0.54% (Cytal), 
2.75% + 0.54% 
(Purisole)
- Ringer's 
acetate
Specific side 
effects if absorbed
hemolysis, 
hyperkalemia, 
hyponatremia, 
shock, renal 
failure, cerebral 
edema
Hyponatremia, 
CNS-inhibition, 
cerebral edema, 
encefalopathy, 
myocardial 
ischemia
Hyponatremia, 
drives water 
out of the 
cells, diuretic 
effect
Diuretic effect, 
hyperglycemia, 
dysnatremia
Hyper-
chloremic 
acidosis, 
reduces 
GFR
None
* Pharmacokinetic parameters for isotonic saline and Ringer’s lactate are based on  volume 
kinetic data in volunteers [25]. These fluids are not metabolized thus the half-life solely describes 
distribution and urinary excretion which are influenced by stress, volume status and anesthesia. 
Abbreviations: Glomerular filtration rate (GFR), total body water (TBW).
4.2.1 General complications of absorption
Using irrigating fluids always entails the risk of absorption. In nearly half of all 
TURPs performed, an absorbed volume greater than 150 ml can be detected [10]. 
With increasing volumes, the risk of adverse effects and symptoms progress. 
Regardless of the solution being used, this affects fluid balance. In addition, 
homeostasis may be disturbed, especially if a non­electrolyte containing irrigant 
6is used. Further specific risks varies between different solutions. Based on that 
massive irrigating fluid absorption was first described during TURP it is referred to 
in the literature as the TUR­syndrome. Large scale TUR­syndrome, which is most 
commonly seen during TURP and TCRE, occurs if absorption is in excess of 3 L 
but this is quite rare [26­28]. An incomplete form, developing in the response to 
1­2 L of absorption is more often the case. This is seen in <1 to 10% of all TURPs 
or equivalent surgeries performed including TCRE [11, 29­34]. The unprecise 
incidence may be due to that most studies do not include a sufficient amount of 
patients to give a really good estimate of the frequency of absorption. The risk of 
absorption is increased in TCRE of fibroids and smokers undergoing TURP [35­37].
Effects on homeostasis include hypocalcemia, dilution coagulopathy, electrolyte 
and acid­base balance disturbances [36­49]. These changes are directly related to 
the amount of absorption although they may be further aggravated depending on 
the type of irrigant used as described in the following sections. All electrolyte­free 
irrigating solutions cause hyponatremia when absorption occurs. For the intra­
vascular route this is most pronounced at the end of absorption while extravasation 
causes sodium to flow from the extracellular space to the pool of absorption. This 
yields a delayed hyponatremia, typically for 2 to 4 hours, and promotes hypo­
volemia [50­52]. 
Effects on fluid balance can be viewed both from a local and a systemic perspec­
tive. Local symptoms can occur when there is extravasation and this includes pain 
and obstructed passage in adjacent conduits. Airway obstruction has been reported 
in shoulder arthroscopy while, in urological or gynecological surgery, local drain­
age may be attempted [6]. Based on the pathophysiology of extravasation and as 
shown with increasing amounts of absorption, the risk of hypotension, abdominal 
pain and bradycardia is increased in case of extravasation [53]. Systemically, fluid 
absorption causes hypervolemia which obviously entails a risk of fluid overload 
and pulmonary edema, especially if there is also hyponatremia [54]. However, 
in many cases this is only transient and followed by a hemodynamically hypo­
kinetic phase with low cardiac output, low blood pressure and hypovolemia [55, 
56]. The cause is multifactorial and originates from osmotic diuresis, natriuresis 
and that with hypo­osmotic irrigants there is also an intracellular uptake of water. 
The release of endotoxins from the surgical field and changes in homeostasis such 
as hypocalcemia, hypo­osmolality and mild hypothermia may be of additional 
importance [56­59]. 
Hyponatremia and hypo­osmolality can also cause neurological symptoms ranging 
from mild dizziness to decreased levels of consciousness, epileptic seizures and 
brain edema [28, 32, 60­61]. Further organ specific effects that may be seen include 
renal hypoxia and myocardial uptake of water with release of troponin, bradycardia 
and other ECG changes as signs of strain [26, 47, 50, 62­69]. Myocardial  infarction 
7has been reported in 0.5–3% of TURPs performed [69­71]. Overall mortality from 
severe TUR­syndrome was estimated to 25% in a French review comprising 24 
patients with massive absorption of glycine 1.5% [72].
4.2.2 Non-conducting solutions
Sterile or distilled water was the first irrigating solution used and its use in this 
context dates back to 1926 when McCarthy introduced the TURP procedure. Since 
water hemolyse erythrocytes, it provides the best visibility in the surgical field in 
case of bleeding. If absorption occurs, water is freely distributed in the total body 
water (TBW) so that hyponatremia may be less pronounced than for other non­
electrolytic irrigants. The hemolysis may give hyperkalemia, anemia and cause 
renal failure since free hemoglobin damages the epithelium of Henle's loop and 
distal convoluting tubuli [16]. The adverse effects may be fatal and sterile water 
is now only recommended in diagnostical procedures but, perhaps due to its low 
cost, it is still used in some TURPs worldwide [73­74].
Glycine is the most inexpensive irrigant after sterile water and has long been 
dominating the market of electrolyte­free irrigating solutions. It is an endogenous 
nonessential amino acid with no risk of allergies. Glycine acts as an inhibitory 
neurotransmitter, especially in the retina and absorption has been shown to cause 
visual disturbances and transient blindness [75]. Liver metabolization produces 
glycolic acid, glyoxylic acid, glutamate and ammonia that all have been linked to 
various neurological symptoms including encephalopathy [76­79]. About 10% of 
the absorbed volume is eliminated unchanged via the kidneys resulting in osmotic 
diuresis with loss of sodium [80]. In addition, glycine stimulates secretion of 
vasopressin and atrial natriuretic peptide which further promotes hyponatremia 
through water retention respectively natriuresis [81­84]. Compared to absorption 
of other irrigating solutions, cellular edema becomes more severe with glycine and 
the risk of myocardial cell damage is increased [85­86]. Glycine has been used 
in different concentrations from 1.0 to 2.2%. 1.5% is the most commonly used 
and is slightly hypo­osmotic. The other mixtures offer no advantage and lower 
concentrations increases the risk of hemolysis while higher can aggravate toxic 
adverse effects [87­89]. 
Mannitol is not metabolized in the body but excreted unchanged in the urine. The 
5% concentration is the most widely used mannitol solution for irrigation pur­
poses. It is a powerful osmotic diuretic but being nearly iso­osmotic it still does 
not affect osmolality even though electrolytes are lost. More diluted mannitol 
solutions are used in the treatment of brain edema and to induce forced diure­
sis. Compared to glycine, it has no neurological toxic effects, no risk of cerebral 
edema and causes less myocardial damage although the risk of other circulatory 
symptoms is equivalent [30].
8Sorbitol is metabolized in the liver to fructose and glucose, which in rare cases 
may result in lactic acidosis respectively hyperglycemia [90]. Just like glycine, 
about 10% is excreted unchanged in the urine inducing osmotic diuresis [91]. It is 
available in several mixtures with mannitol and with a total concentration around 
3%. Overall symptoms of sorbitol absorption are the same as for glycine [69]. 
Treatment in case of non­conducting irrigating fluid absorption should focus on 
the administration of hypertonic saline [92]. If pulmonary edema or prolonged 
fluid overload is evident, additional treatment with diuretics should be considered 
but only after stabilization of the hemodynamics [93].
4.2.3 Electrolyte-containing solutions
As stated previously, electrolyte­containing solutions can be used when monopolar 
cautery is not needed. Isotonic saline (NS) is most commonly used for this purpose 
but balanced solutions like acetated or lactated Ringer’s solution could be a bet­
ter alternative. There are no studies comparing the absorption effects of balanced 
crystalloids versus NS when used as an irrigant. However, there are numerous 
studies comparing the two when used for intravenous infusion therapy and which 
is the better has been a long ongoing debate.
NS contains 154 mmol sodium and chloride per L yielding a strong iron differ­
ence of 0 which in turn promotes hyperchloremic metabolic acidosis. RS, on the 
other hand, has a sodium content of 130 and chloride 100 mmol/L which gives 
a more balanced strong iron difference of 30 mmol/L as compared to the normal 
38 in plasma. Thus no acidosis is promoted. Of particular interest to the anesthe­
tist are some of the pharmacological effects of acidosis which include attenuated 
catecholamine response, potassium shift from the cells, increased arrythmogen­
ity of inhalation anesthetics as well as potentiation of opiates and neuromuscular 
blocking agents. In addition, as renal cells in the macula densa sense an increase 
in sodium and chloride concentration this triggers the physiological tubuloglo­
merular feedback mechanism which works to maintain an optimal salt and water 
balance. The effect is vasoconstriction in the afferent renal arteriole with a reduced 
glomerular filtration rate (GFR).
NS was found to increase vasopressor requirements, mortality and acute renal 
failure incidence respectively frequency of major adverse kidney events in three 
recently published studies comprising goal directed fluid therapy in abdominal 
surgery and volume substitution in critically ill and non­critically ill adults [22­24]. 
The average volume administered ranged from 1 to 3.5 L which is in the spectrum 
of incomplete TUR­syndrome.
94.3 Monitoring of irrigating fluid absorption
The first assessments of fluid absorption were through clinical evaluation of symp­
toms. Since then this method has evolved with symptoms being more defined and 
with grading of their severity. Sedation, anesthesia and comorbidities may confound 
the approach. The clinical symptoms entails chest pain, bradycardia, hypertension, 
hypotension, poor urine output, blurred vision, nausea, vomiting, uneasiness, con­
fusion, tiredness, decreased levels of consciousness and headache. The duration, 
severity and number of symptoms correlates with the amount of irrigating solution 
absorbed. In a study using glycine 1.5% by Olsson et al, the number and severity 
of symptoms progressed with increasing fluid absorption. The average amount of 
symptoms was 1.3 for volumes of 0–300 ml, 2.3 for 1–2 L, 3.1 for 2–3 L respec­
tively 5.8 for absorptions exceeding 3 L as measured by the ethanol method [50].
For absorption of non­conductive solutions, blood samples for measurement of 
sodium dilution or plasma concentration of the irrigating substance at the end 
of the surgery correlate with the absorbed volume [94­98]. The rate and type of 
absorption, TBW, intravenous infusions and elapsed time from absorption may 
influence the detected levels. Analysis of mannitol, sorbitol or glycine is usually 
not readily available in clinical practice but sodium dilution may be used to vali­
date or refute absorption of electrolyte­free irrigants. When measured at the end 
of surgery, a depression of sodium by approximately 10­12 mmol/L in males and 
20 mmol/L in females corresponds to an absorption of 2 L [95, 99­100].
Direct measurements of fluid absorption includes volumetric, gravimetric and 
tracer techniques. The advantage is that absorption may be indicated early, before 
the patient becomes symptomatic and that the further extent of surgery can be 
modified in order to avoid massive absorption. For volumetric measurements all 
fluids that enters and exits the patient have to be accounted for. Visual estimates 
have been found unreliable especially due to spillage on the floor, bag to bag vari­
ations in volume and admixing of blood and urine to the retrieved irrigating fluid 
[101­102]. The method works better for TCRE where there is less blood loss and 
automated fluid tracking systems are available [103]. Gravimetry uses a bed­scale 
for repeated weighing of the patient during the operation. The method is rather 
accurate assuming measurement are performed with an emptied urinary bladder 
and that blood loss and intravenous infusions are accounted for [104­105].
In tracer techniques a small amount of a traceable substance, i.e. an isotope or 
ethanol, is added to the irrigating solution. Isotopes reliably detects fluid absorp­
tion but radiation hazards makes the method hardly warranted today. The use of 
ethanol as a tracer was first suggested in 1986 [106]. The technique has since then 
been used and evaluated in numerous studies and surgeries of the genitourinary 
tract, especially during TURP and TCRE [11, 107]. Ethanol does not passively 
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diffuse across the endothelium of these defined anatomical spaces and hence the 
uptake of ethanol is directly proportional to the absorbed volume. An ethanol con­
centration of 1% (13.3 ml 95% alcohol per L) in the irrigating solution is used and 
expired breath concentrations are measured at least every 10 min during surgery. 
The patient makes an exhaled breath in the alcolmeter during spinal anesthesia 
and for general anesthesia it is possible to adapt the alcolmeter to the breathing 
circuit. If the patient exhales too vigorously there may be movement involved 
that disturbs the surgical procedure. Obtained values are affected by the elimina­
tion and distribution kinetics of ethanol. For clinical practice there are available 
nomograms for quick estimates of the ethanol samples corresponding amount of 
absorption and degree of hyponatremia [107]. An example of such a nomogram 
is given in figure 1 below. In scientific studies, an equation is used to give more 
precise results [108].
Figure 1. Nomogram for estimation of the absorbed volume and corresponding change 
in serum sodium concentration at any given time when an electrolyte-free irrigant con-
taining 1% ethanol is used during TURP. The dotted line indicates the 90% prediction 
interval. The lower part of the figure indicates a scale for additional corresponding 
 volume based on the distribution and elimination of ethanol over time. I.e. if the measured 
ethanol concentration is 0.2 the corresponding volume is 1200 ml. If positive tests have 
been recorded for 30 min an additional volume of 300 ml is added giving a total volume 
of absorption of 1500 ml [107].
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5 NITROUS OXIDE
5.1 Properties
Nitrous oxide (N2O) was first discovered in 1793 
by the English scientist Joseph Priestley. Initial use 
was for recreation and public shows. Procedural 
use, mainly for tooth extraction, commenced in 
the early 1840s [109]. Main medicinal uses today 
are for minor pain, sedation, and as complement 
in anesthesia giving faster and smoother induction, recovery and better hemo­
dynamic stability. N2O is an inert gas with good analgesic and anxiolytic, but 
weak anesthetic effects. It is produced through heating of ammonium nitrate to 
a temperature between 245–270 degrees Celsius. After cooling and purification, 
N2O is evaporated and stored compressed in aluminum tanks at a pressure of 50 
bar (5000 kPa). The cylinder then contains a mixture of N2O in its vapor and liquid 
form and thus the total quantity of gas can only be ascertained by weighing. It is 
a sweet smelling, colourless, non­irritant, non­flammable gas but it strongly sup­
ports combustion, even in the absence of oxygen. Due to this, N2O should not be 
used in the presence of sources of ignition, oils, grease, alcohol gels and many 
plastics [110­111].
The nociceptive mechanisms of action are attributed to spinal inhibition and 
especially supraspinal activation of opioidergic neurons in the locus ceruleus 
and periaqueductal grey matter of the brainstem via hypothalamic release of 
corticotrophin­releasing factor. This activates descending noradrenergic inhibitory 
pathways [112­116]. In specific this may be related to the presynaptic release of 
endogenous ligands, such as dynorphine, enkephalin and endorphin that binds to 
kappa­opioid receptors. Thus, the effect is comparable to that of morphine and may 
be inhibited by the opioid antagonist naloxone [117­125]. Anxiolytic properties, 
on the other hand, are mediated through Ƴ­aminobutyric acid (GABA)A receptors, 
similar to the mechanism of action for benzodiazepines, and may therefore be 
inhibited by flumazenil [126­129]. Anesthetic and dissociative effects involve a 
broader spectra of ligand­gated ion channels, especially the GABAA­ and N­methyl­
D­aspartate (NMDA)­receptors [130­133]. Thus, N2O affects several different 
receptors. These effects are dose dependent.
The potency of an anesthetic gas is related to its partial pressure in the brain. 
Alveolar concentration is generally accepted as an index of this because it can be 
actually measured. This potency is described as the Minimal alveolar concentration 
(MAC), which is defined as the alveolar concentration (in volumes percent at a 
pressure of 1 atmosphere absolute) of an anesthetic gas at which 50% of patients 
show no movement upon skin incision. With a MAC of 104%, N2O is the least 
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potent of available anesthetic gases. Concentration, described as the fraction of 
inhaled gases, required for general anesthesia is so high that it does not allow for 
adequate oxygen delivery. Indeed, early clinical use was disreputed due to the risk 
of severe hypoxemia. Although N2O is usually insufficient for providing adequate 
anesthesia unless combined with another volatile agent it is still a potent analgesic, 
even in sub anesthetic doses. Several studies have shown clear analgesic effects 
when N2O is administered at a concentration of around 15–20%. Psychomotor 
effects may be seen at even slightly lower doses [134­140].
In this thesis, N2O was dissolved in fluid and used as a tracer to detect irrigating 
fluid absorption. The reasons for choosing N2O were that elimination through 
urine is negligible, it is not metabolized in the body, concentration in ambient air 
is negligible, and it has a low blood/gas solubility coefficient of 0,47 at 37 degrees 
Celsius. The overall physical properties are listed in table 2. Importantly, nitrous 
oxide can be measured in very low concentrations, down to parts per million (ppm).
Table 2. Physical properties of nitrous oxide [110].
N2O physical properties
Molecular weight 44 Da Ostwald solubility coefficient at 37°C:
Boiling point  –88°C Blood/gas 0.47
Saturated vapour pressure 5300 Kpa at 20°C Fat/blood 2.3
MAC 104% Oil/gas 1.4
Oil/H2O 3.2
The low blood/gas solubility means that cardiac output and minute volume have 
little effect on the rate of equilibration of inhaled N2O (figure 2) and that it, like 
all volatile anesthetics, is quickly eliminated through the lungs. In fact, rise time 
in alveolar concentration as well as elimination is faster than for any other anes­
thetic. Although not very soluble, N2O is still fifteen times more soluble than 
oxygen and can be dissolved in water and plasma up to 100 respectively 45 vol­
umes percent [111].
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Figure 2. Influence of cardiac output (A) and minute volume (B) on the rate of equili-
bration between alveolar/end-tidal (FA) and inspired (Fi) concentrations of nitrous oxide 
during non-rebreathing conditions (NRB) and a circle system with a fresh gas flow of 
1 L/min. Due to the low solubility of N2O, changes in alveolar  concentration and  cardiac 
output have little effect on the rate of equilibration of inhaled N2O [Modified from Conway 
CM. Gaseous homeostasis and the circle system: Factors influencing anaesthetic gas 
exchange. Br J Anaesth 1986; 58:1167-1180].
5.2 Side effects and patient risks
The contraindications for using N2O are few and attributed to the risk of expanding 
gas filled cavities and affecting vitamin B12. Due to the much higher blood/gas 
partition coefficient of nitrous oxide as compared to nitrogen (0.015), it passes in 
to any air filled space faster than nitrogen is eliminated and may give a 3–4 fold 
increase in volume. This can aggravate numerous conditions i.e. pneumothorax, 
pneumoperitoneum, trauma with entrapped air in sensitive areas, air embolism, 
hypoxemia, the use of air filled cuffs, and various types of head surgery [111]. N2O 
inactivates cobalamin (vitamin B12) through oxidization of the cobalt I form. It may 
also generate hydroxyl radicals that irreversibly oxidize cobalamin. This prevents 
vitamin B12 from, together with 5­methyltetrahydrofolate, acting as a coenzyme 
for methionine synthase and thus causes a dose dependent inhibition of its enzyme 
activity. Methionine synthase is essential for generating methyl groups that are 
necessary for a series of processes such as DNA, RNA, myelin and catecholamine 
synthesis [141]. Prolonged or frequent use of N2O may cause agranulocytosis, 
bone marrow dysplasia, megaloblastic anemia, neuropathies, and degeneration 
of the spinal cord [142­143]. Nitrous oxide should not be used in patients with 
abnormalities of the vitamin B12 metabolism, although sub anesthetic or short 
procedural administrations have not been studied. Teratogenic effects and repro­
ductive toxicity have previously been considered but are now refuted [144­148].
Side effects and adverse events in patients were finally addressed in the ENIGMA­II 
trial including over 7000 patients randomized to anesthesia with or without N2O 
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in major non­cardiac surgery. Apart from a slightly increased N2O incidence of 
severe nausea and vomiting, which could be controlled with antiemetic drugs, no 
statistical differences were seen between any group outcomes [149].
5.3 Occupational and environmental aspects
The risks of occupational exposure to anesthetics has led to the introduction of 
occupational exposure limits (OELs) which are expressed as a 8­hour time­weighted 
average. Additionally, some countries have also adopted a short­term exposure limit 
to set a standard for maximum concentrations not to be exceeded even for short 
periods. The OEL for nitrous oxide varies, from 25 to 100 ppm, between different 
countries as it is set by national institutes [150­152]. In comparison, environmental 
nitrous oxide levels were typically in the range of 1000–2000 ppm before scaveng­
ing systems were introduced. Proposed health risks for providers are generally 
the same as for patients in regard to the effects of inactivation of vitamin B12. 
Additional concerns have been raised that repeated and prolonged exposure to a 
mix of volatile anesthetics may cause genotoxicity [153­155]. This effect seems 
to be reversible and is not apparent when N2O is used as a sole agent [156]. It has 
also been proposed that inhibition of methionine synthase may increase the risk 
of miscarriage and postnatal development impairment. Although several studies 
have addressed this, no data supports the concern as long as exposure levels are 
kept within recommendations [157­159]. In summary, there is no evidence of 
any hematologic, neurologic or reproductive occupational risks as long as OELs 
are not excessively exceeded to 500 ppm or more [160­163]. Indeed, in 2015, 
the European Society of Anesthesiology task force on the use of nitrous oxide in 
clinical anaesthetic practice stated that there is no evidence indicating an increased 
health risk for patients or providers in a clinically relevant setting [164].
Global environmental N2O concentrations are steadily rising at a rate of 0.7 to 
0.8 parts per billion per year. This is an important issue since N2O, along with 
CO2 and methane, is one of the most influential greenhouse gases that are listed 
in the different agreements within the United Nations Framework Convention on 
Climate Change (UNFCC), i.e. the Kyoto protocol, Doha amendment and Paris 
agreement. The global warming potential of N2O is attributed to ozone depletion 
and the obstruction of thermal radiation flux from the earth’s surface up through 
the stratosphere. 1 – 3% of N2O emissions derive from healthcare [165]. Other 
main sources are from combustion of fossil fuels and solid waste, fertilizer use, 
and especially natural microbial actions in soil and water. Although the contribu­
tion of N2O emissions from healthcare are relatively small, the effects on global 
environment are just as important. Thus, adequate scavenging systems and waste 
handling systems are necessary together with a conscious and responsible use. 
The effectiveness of global climate strategies was underlined in a 2018 United 
Nations report which, for the first time since the 1970s, showed that the ozone 
layer is now healing [166].
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5.4 Measuring nitrous oxide concentrations
Measuring nitrous oxide concentrations is of interest in numerous scientific fields 
such as in global and local environment issues, occupational exposure and medi­
cine. This has driven the development of several different analytical instruments 
which all have their pros and cons. Measurements can either be performed by 
estimating the flux or vertical and horizontal air flow related change over time in 
a specific area (i.e. Eddy covariance, Eddy accumulation, flux­methods or disper­
sion techniques) or by collecting samples in a specific liquid or closed chambers. 
The latter are the methods used in measurements regarding occupational exposure 
and medicine. The analysis becomes more accurate if the chamber size is increased 
but at the same time the instrument becomes less portable. 
Figure 3. The NGA 2000 MLT Analyzer (Rosemount Analytical, Hasselroth Germany), 
used in papers 2 and 3, measures N2O and CO2 concentrations via absorption of infra-
red light.
The actual analysis of N2O concentrations is done either through chromatographic, 
optical or amperometric techniques although additional methods are under develop­
ment. Gas chromatography, using an electron­capture detector, is the most widely 
used analytical method. It is accurate and relatively cheap but requires frequent 
calibration and does not allow for continuous measurements. 
For use at room temperature, optical techniques use either infrared light or Quantum­
cascade lasers. Absorbance at a specific wave length gives a measurement of 
the concentration of the gas. For N2O, this wavelength is around 4 micrometers. 
Accuracy can be further enhanced by using longer path­lengths, multiple passes 
or optical lenses and mirrors that increase the points where the beam can be 
absorbed. Optical techniques have low calibration requirements and allows for 
quick, continuous measurements. Instruments are, however, more costly than for 
other analytical methods. 
Amperometric sensors measures N2O concentrations through the current that 
occurs when N2O interacts with an electrode. Instruments have a low cost but are 
sensitive to sensor drift and can only measure dissolved N2O [167].
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6 GLUCOSE HOMEOSTASIS AND KINETICS
In paper IV glucose was investigated as a potential tracer to detect or refute irri­
gating fluid absorption of electrolyte­containing solutions. Glucose homeostasis 
is normally regulated through a closed feedback loop including a variety of hor­
mones, especially insulin and glucagon, and a multitude of organ systems such as 
the liver, pancreas, central nervous system, muscles, and adipose tissue. Increase 
in blood glucose levels are due to glycogenolysis, gluconeogenesis, or exogenous 
administration. Glucose concentrations decrease as glucose enters the cells either 
through facilitated diffusion or active transport involving glucose transporters. If 
levels are above 12 to 15 mmol/L there is also glucosuria. However, in normal 
conditions, fastening levels are kept below 7 mmol/L. Iv infusion of a glucose 
solution usually increases insulin secretion which normalizes blood glucose levels 
within about 30 min from the end of the infusion [168]. Stress, critical illness and 
trauma including most types of surgery causes insulin resistance and increased 
endogenous glucose production which alters these dynamics resulting in a delayed 
clearance [169]. The plasma volume correlates with the glucose level as its osmotic 
force influences the distribution of water in the body.
6.1 Pharmacokinetics
Measuring the distribution of a glucose solution in the body can be done by isotope 
labeling. In addition to the limitations of using radioisotopes there are also the 
assumptions and issues of the water volume not necessarily distributing in the same 
way as the labelled molecule and that the techniques are time consuming and can­
not describe dynamic processes. An alternative method is that of volume kinetics.
In basic pharmacokinetics, the volume of distribution (Vd) describes the theoretical 
volume over which a substance is spread. It is thus a description of the relation­
ship between the administered dose and the measured concentration in plasma. 
Clearance (CL) is the theoretical plasma volume from which the substance is 
completely removed per unit of time. This reflects both the plasma concentration 
and the elimination through excretion and metabolization. In volume  kinetics, these 
pharmacokinetic principles are used to describe the turnover of an iv  infusion. There 
are two key differences in this concept; one, the infused  volume is an important part 
of the volume of distribution and two, the dilution effect on endogenous substances 
is used instead of measuring the drug concentration. Dilution of hemoglobin (Hgb) 
and sodium correlates to the fractional volume effect in plasma respectively the 
extra cellular space. As the plasma part of blood is 1 minus the hematocrit (Hct), 
the plasma dilution is derived from the hemodilution by dividing the ratio of start­
ing Hgb/diluted Hgb with 1 – Hct. The plasma dilution variables, glucose con­
centrations and rate of infusion are entered in a computer program (in this thesis 
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we used Matlab version 4.2, Math Works, Nastick MA) that performs a random 
search method for the least­squares fitting procedure to obtain the unknown vari­
ables. Compartmental nomenclature is used since volume kinetics is an advanced 
pharmaco kinetic model that describes the expansion of functional rather than 
physiological fluid spaces and the compliance for volume expansion varies within 
physiological fluid spaces [170­173]. Depending on the type of fluid, situation and 
rate of infusion a one, two or even three compartment model may be used [174]. 
Assuming there is no marked glucosuria, the escape of glucose into the cells can 
be derived from its Vd and thus the differences in actual blood or plasma glucose 
concentrations can be converted to the number of glucose molecules in their Vd. 
Some of the advantages with volume kinetics include that it is minimally inva­
sive, gives a dynamic analysis and that it allows for the prediction of effects of 
simulated infusions. In paper IV a one compartment turnover model, as described 
in figure 3 below, was used to describe the kinetics of glucose and the accompa­
nying water volume.
Figure 4. One compartment turnover model of glucose kinetics and the accompanying 
water volume.
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7 AIMS
The overall aim of this thesis was to improve patient safety by understanding better 
the pathophysiology of overload with irrigating fluid and to explore the potential 
use of two new markers to detect fluid absorption. More specifically this meant 
to investigate and answer the following questions:
Explore the effects of massive absorption of glycine and mannitol, two commonly 
used electrolyte­free irrigating solutions. Are there any fluid related differences 
with regards to the pathophysiology? If so, how are these disturbances gradually 
developed on an organ specific and whole body level?
Investigate new diagnostic tools for monitoring of irrigating fluid absorption. Can 
nitrous oxide be added to the solution as a tracer for early detection of absorption? 
If so, what is the most suitable concentration and sampling device? How well does 
the nitrous oxide levels correlate to the amount of absorption? Can the method 
differentiate between the two routes of absorption? Is the technique practically 
feasible in a clinical context? Are there any adverse effects?
Does the addition of glucose 1% to the irrigating fluid allow for validation or dis­
missal of suspected absorption when electrolyte changes are absent? If so, how 
may glucose levels correlate to the total absorbed volume of different patterns?
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8 METHODS
Paper 1 was an experimental infusion study in pigs aiming to describe the gradual 
development of the pathophysiological mechanisms involved in massive irrigating 
fluid absorption also known as the TUR­syndrome. In papers 2 and 3 we investi­
gated the use of nitrous oxide for instant detection of irrigating fluid absorption. 
Study 2 was performed in healthy volunteers while the third paper was executed 
as a good clinical practice (GCP) study in TURP­patients. Here we reported all 
findings to an external and impartial review board. 
One of the reasons why the ethanol method (as described in section 3.3) has not 
been implemented more widely in clinical practice is that there is no patent for it. 
Educational costs and technical devices are often sponsored by healthcare compa­
nies holding a patent. In hopes of developing a method that would gain as many 
patients as possible a European patent registration was applied early on. AGA 
Linde healthcare AB, who manufactured the nitrous oxide used, helped arrange 
the application and after approval the patent rights were transferred to them. AGA 
Linde healthcare financially supported papers 2 and 3 by providing some of the 
equipment for admixing nitrous oxide in the irrigating fluid as well as lending the 
MLT analyzer, and the accompanying software, used for measuring nitrous oxide 
concentrations. Results were continuously reported to the company’s research 
and development group although AGA Linde healthcare had no part in the design, 
execution, interpretation of results or presentation of the studies.
Before study 4 the bipolar TURP technique was introduced. Previously sodium­
free irrigating solutions had been used and absorption could then be validated or 
refuted by measuring the degree of sodium dilution. Since this is not possible when 
isotonic saline or Ringer’s solution is used as the irrigant we wanted to investigate 
if the addition of glucose 1% could compensate the loss of this diagnostic tool.
8.1 Subjects and irrigating fluid administration
In paper 1, twenty­five pigs of both sexes aged between 8 and 10 weeks and with a 
mean BW of 22 (19–29) kg were acclimatized in a sty next to the operating room 
at the animal research facility of Södersjukhuset, Stockholm for at least 3 days 
before the experiments. Two pigs served as controls, receiving no infusion, and 
the other 23 were randomized to a 90 min constant rate infusion of 100 mL kg/h 
of either glycine 1.5% w/v (n = 9), mannitol 5% (n = 8) or mannitol 3% (n = 6). 
Interspecies scaling, adjusting for differences in metabolic rate and  toxicokinetics, 
suggests that the toxic effect of the infused fluid corresponds to 40 mL/kg/h 
(≈ 3.2 L/h) in an adult male. The mannitol 3% infusions were administered to 
compare the effects on intracranial pressure with glycine 1.5% as these solutions 
have the same osmolality. After anesthetic induction and surgical preparation the 
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animals were allowed to reach hemodynamic steady state for 30 min before the 
infusion started. Monitoring and observations continued over a total of 120 min 
after which the animals were killed with an overdose of thiopental and ethanol.
Paper 2 and the experimental part of study 4 included 12 respectively 10 healthy 
male volunteers aged 19­52 (median 26) and 20–41 (mean 30) years. Their BWs 
were 65–88 kg (median 76) respectively 72–111 (mean 85) kg. Volunteers had 
a light breakfast at home and were not allowed to eat or drink during the experi­
ments, before which they rested supine for 20 min to reach a haemodynamic steady 
state. Paper 2 experiment were performed at the clinical research and metabolic 
laboratory facilities of Södersjukhuset, Stockholm while study 4 took place at the 
Clinical Research Center at Södertälje Hospital in Sweden.
In paper 2 the volunteers underwent four series of experiments aimed at evalu­
ating different aspects of monitoring the administration of iv fluid by means of 
expired­breath tests using N2O as a tracer. In unpublished data and a pilot study 
in pigs it was found that N2O is not absorbed from the urinary bladder and that 
infusion of an irrigating solution to which N2O had been added to a concentra­
tion of 10% yielded end expiratory gas concentrations of approximately 300 ppm 
[175]. Infusion experiments, in volunteers, could thus be used to further investigate 
the correlation between the amount of irrigating fluid absorbed and exhaled N2O 
concentrations. The infusion regimens used were:
1) Seven 5­min continuous rate infusions of Ringer’s solution 1 ml/kg for com­
paring sampling sites. The N2O was added to Ringer’s since hyponatraemia 
and breath ethanol levels were not assessed as in the other experiments.
2) Continuous infusion of 15 ml/kg of Mannitol 3% and ethanol 1% over 20 min. 
The total infused volume was 1146 (SD 110) ml.
3) One of three volumes of either 7.5, 12 or 15 ml/kg as an intermittent infusion 
of mannitol 3% and ethanol 1%. The intermittent infusion paterns are shown 
in figure 5 below.
4) A intermittent infusion administred in the same regimen as in experiment 3 
but with 40% of the volume and 2.5 times higher N2O concentration.
N2O was added to a concentration of 40 ml/L in all infusions except in number 
4 where the concentration was 100 ml/L. The experiments were performed on 
separate occasions at least 2 days apart besides in the comparison of sampling 
sites, which were performed shortly after experiment 3. Randomization for the 
order of infusions and volumes used in experiments 3 and 4 was made by sealed 
envelopes. Measurements continued until the N2O concentration had returned to 
baseline, which occurred about 10 min after the administration of N2O had ended, 
except in experiment 2 where the volunteers were followed for 100 min to allow 
a follow up of the fluid balance to be made.
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Figure 5. The intermittent infusion patterns as administred in study 2, experiments 3 
and 4.
The rationale for the infusion regimens used in paper 2 was that the continuous 
infusions were intended to simulate extravasation. Intraperitoneal infusions of 
N2O­containing irrigating fluid in pigs show that a continuous pattern of breath 
N2O develops, similar to that when ethanol is used as a tracer. The intermittent 
infusions mimicked absorption of irrigating fluid by the direct iv route during 
intermittent filling of the bladder, as such absorption can only occur in bursts 
whenever the pressure exceeds the prostatic venous pressure of about 1.5 kPa. The 
three intermittent infusion patterns used were based on actual absorption cases 
from our clinic in which the pressure in the bladder and fluid uptake had been 
measured simultaneously. The same data have been used previously for simula­
tion purposes. A maximum amount of 600 ml of N2O can be dissolved in 1 L of 
water at room temperature [176]. Mixing is facilitated by letting the gas diffuse 
through the fluid. A bubble is created in the upper part of the fluid bag, which con­
sists mainly of displaced N2, with which irrigating fluid is always saturated. The 
N2O concentration of only 40 ml/L was chosen because concentrations exceeding 
100 ml/L might increase a theoretical risk of explosion during electric cutting. 
N2O mixes with gases formed during electric cutting, such as propane, which can 
gather in air pockets within the area of surgery.
For the experimental part of paper 4, Acetated Ringer’s solution, 20 mL/kg, to 
which 34.5 mL of glucose 300 mg/mL had been added to reach a concentration 
of 10 mg/mL (1%), was infused at a constant rate over 30 min. Monitoring and 
observations continued over a total of 160 min. The reason for choosing a glucose 
concentration of 1% was that 5% glucose, as indicated by the results of the clini­
cal part of the study, could increase plasma glucose to levels far above those that 
result in glucosuria, and thus seemed unnecessarily high.
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Infusion pumps were used in all animal and healthy volunteer experiments for 
the controlled administration of exact volumes. The mannitol 3% and ethanol 1% 
solution used has an osmolality of 400 mosm/kg.
Paper 3 and the clinical part of study 4 included 86 respectively 250 males, aged 
67 to 85 (median 75) and 48 to 96 (mean 74) years old and scheduled for elective 
TURP. Their BWs were 73–86 kg (median 80) respectively 55–135 (mean 79) kg. 
Surgeries were performed at Södersjukhuset and Huddinge sjukhus, Stockholm 
respectively at Southmead and Torbay Hospitals in the United Kingdom. The size 
of study 3 was chosen based on an incidence of fluid absorption of 30% and that 
10% of the patients absorb > 1 L of fluid [29­30]. Additional comparisons between 
the ethanol and N2O method would also be possible during the accumulation of 
increasing volumes in cases with absorption. Exclusion criteria in the study were 
renal or liver disease, that general anesthesia (which would not allow for breath 
sampling during spontaneous breathing) was indicated or mannitol intolerance 
as the irrigating fluid used was mannitol 3% and ethanol 1% to which N2O was 
added to a concentration of 40 ml/L. In paper 4, the patients were randomized to 
receive either 1.5% glycine or 5% glucose in water as the irrigation fluid. Diabetics 
were not excluded.
8.2 Techniques and preparations
In paper 1, the anesthesia for all the pigs comprised intramusculary administered 
premedication with 20–30 mg of diazepam, 400–500 mg of ketamine and 1 mg of 
atropine. After being weighed to the nearest hectogram on a balance scale, a can­
nula was inserted into an ear vein for iv induction with 300–600 mg of thiopental, 
150–250 mg of ketamine and 5–10 mg of diazepam. Endotracheal intubation was 
then performed and a Servo Ventilator 900C was used for continuous ventilation 
with a ventilator rate of 20–24 breaths/min to keep normocapnea. Adequate  surgical 
anesthesia was maintained by 600–900 mg/h of ketamine and intermittent doses 
of 10 mg of diazepam. The depth of the anesthesia was checked repeatedly by 
pinching the skin between the hoofs.
The surgical preparation included a neck incision for dissection of the left external 
jugular vein and placement of three catheters, one with the tip as close as pos­
sible to the base of the skull for blood­gas sampling, one directed to the heart for 
administration of maintenance anesthetics and irrigating fluid and finally a flow­
directed thermodilution fiberoptic PA­catheter, size 5.5 F for measurements of 
mixed venous blood gases, pulmonary arterial pressure, and cardiac output. The 
right carotid artery was dissected and a perivascular ultrasonic flow probe applied 
for continuous blood flow rate measurement. Via an incision in the left groin, a 
catheter was introduced into the femoral artery to monitor the pressure and draw 
additional blood samples. A 15­cm standard Medtronic PS Medical ventricular 
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catheter for ICP monitoring was inserted 5 cm via a skin incision and a drilled hole 
in the parietal bone, about 1 cm lateral to the midline. Its position was verified by 
X­rays after injecting iohexol contrast through the cannula used for measuring 
the intracranial pressure. A laparotomy was also performed and a Foley catheter 
inserted through a cystostomy into the urinary bladder to measure the urinary excre­
tion of fluid and electrolytes. A perivascular ultrasonic flow probe was applied to 
the abdominal aorta. The abdominal midline incision was then closed. The flow 
probes were both connected to a Transonic T101 analyzer.
For the infusion experiments in healthy volunteers (papers 2 and 4), a cannula was 
placed into the antecubital vein for fluid infusion. In paper 2, experiment 2 and 
paper 4 an additional cannula was placed in the antecubital vein of the opposite 
arm and used for drawing blood samples.
Adding N2O to the irrigating fluids, as done in papers 2 and 3, was performed by 
dissolving N2O for medical use, under sterile conditions, shortly (at the most 30 
min) before each experiment. The N2O was taken from a gas tube and withdrawn 
via a 3­way infusion set into a 250 ml graded glass syringe, which was sterilized 
after each experiment. The valve on the infusion set was then switched, and the 
withdrawn gas injected manually through a bacterial filter and a sterile needle into 
the irrigating fluid via the injection port.
The patients in papers 3 and 4 were prepared for undergoing elective TURP accord­
ing to the hospital routines. In study 3 only spinal anesthesia was used.
8.3 Measurements
For the seventeen pigs receiving mannitol 5% or glycine 1% in paper 1, multiple 
determinations of blood flow rates, arterial and intracranial pressures, electro­
lyte status, blood gases, and urinary excretion were performed. For the six pigs 
 receiving an iv infusion of mannitol 3% only the intracranial pressure, electrolyte 
status, and urinary excretion was studied. The two controls, who did not receive 
any fluid underwent monitoring of the intracranial pressure and pulse oximetry.
Hemodynamic measurements were effectuated just before and 5, 10, 15, 20, 30, 
40, 50, 60, 70, 80, 90, 100, 110, and 120 min after the start of the infusion. The 
measure ments included cardiac output, blood pressures in the femoral and pulmo­
nary arteries, blood flow rates in the internal carotid artery and abdominal aorta, and 
the intracranial pressure. The electrocardiogram was monitored for arrhythmias in 
all animals, and a printout for detailed analysis was obtained every 10 min in eight 
of them (three receiving glycine 1.5% and five mannitol 5%). The QT interval was 
corrected for variations in heart rate (QTc) by dividing the length of the interval 
between the onset of the QRS complex to the end of the T wave by the square 
root of the average interval between three consecutive heart beats (RR interval).
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Blood was sampled from the femoral artery to determine the B­Hgb concentra­
tion by using Multi­Species software on a Technicon H1 on the same occasions 
as the hemodynamic measurements. Urine samples were also taken and the urine 
volume was measured before and 10, 20, 30, 40, 50, 60, 70, 80, 100, and 120 
min after the start of the infusion. The serum and urine concentrations of sodium 
and potassium were measured on a Hitachi 917. To detect possible damage to the 
myocardium, the serum activity of creatine phosphokinase was measured on the 
Hitachi 917 and the concentration of troponin T in serum by immunoassay on an 
ES Enzymun system before and 60 min after starting the infusion. Samples for 
measurements of blood gases were obtained from the femoral artery, right atrium 
(mixed venous), and from the proximal part of the external jugular vein on the 
same occasions as the electrolyte concentrations in serum and urine, using an AVL 
995­Hb in the operating room.
After the experiments were completed and the animals were killed, the heart was 
removed from the two controls and 13 of the 17 animals receiving glycine 1.5% 
or mannitol 5%. After rinsing with saline and fixation in buffered formaldehyde 
4%, the hearts were examined, by a treatment blinded investigator, with regards to 
pathological alterations and weight. Light microscopy was used to investigate the 
subendocardial, atrial, and ventricular myocardium. Besides routine  hematoxylin–
eosin staining, Gordon and Sweet’s silver impregnation method was used to  visualize 
collagen and reticulum fibers of the myocardial histoskeleton, i.e., the basal mem­
branes of the capillaries and the matrix. Furthermore, an immunohistochemical 
method for detecting leakage of myoglobin from myocytes was used to demon­
strate early stages of myocardial hypoxia. Rabbit anti­human myoglobin, based 
on a purified immunoglobulin fraction of rabbit antiserum, was tested and found 
useful for this purpose. Observations were scored as 0 (normal), 1 (mild change), 
or 2 (severe change). The score was reduced by 50% if the alteration was found 
only in the subendocardium or deeper in the myocardium. 
For the comparison of sampling sites in paper 2, the N2O concentration was 
 measured, in random order, from a flared nasal cannula, a standard nasal cannula 
and a Hudson mask during spontaneous ventilation. These experiments were 
repeated while oxygen therapy was administered through a separate flared nasal 
cannula at a constant rate of 2 litres of O2/min. In addition, specific recordings 
were made every 30 s at the end of forced exhalations. All other N2O concentra­
tion samples in papers 2 and 3 were via a flared nasal cannula.
N2O and CO2 concentrations, in papers 2 and 3, were measured every second in the 
exhaled breath by the N2O monitor NGA 2000 MLT Analyzer. The monitor consists 
of a temperature­controlled 30 ml sampling unit with pump valves. Gas concentra­
tions are measured by an absorbance technique using infrared signals which do 
not interfere with each other. For N2O, the range was 5–2000 ppm and the pump 
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was set to a suction rate of 300 ml of air per minute. Data were stored directly on 
a laptop computer. The end­expiratory ethanol concentration was  measured at 0, 
5, 10, 20, 30, 40, 50, 60, 80 and 100 min in experiment 2 of study 2 and every 10 
min in paper 3. The subject was asked to take a deep breath and perform a single 
end­expiratory breath alcohol test using a Lion Alcolmeter S­D2. 
Blood samples in volunteers in of paper 2, experiment 2 and in paper 4 were drawn 
from the cannula in the infusion free arm. In study 2 this was done on the same 
occasions as the ethanol samples and for measurement of the blood Hbg and serum 
sodium concentrations. Hbg was analyzed on a Technicon H2 and electrolytes on 
a Hitachi Modular. In the clinical part of paper 4, blood samples were taken just 
before and 5 min after the end of each operation for serum glucose and sodium 
concentration measurements, which were performed by the in­hospital routine 
clinical chemistry laboratory. In the experimental part of the study, blood samples 
were collected at 5­, 10­, and 20­min intervals between 0 and 60 min, 60 and 100 
min, and 100 and 160 min, respectively. Analyses of plasma glucose concentration, 
Hgb, red blood cell count, mean corpuscular cell volume, and baseline hematocrit 
were performed by the hospital clinical chemistry laboratory. Additionally, plasma 
concentrations of sodium and potassium were analyzed at 0, 30, 60, and 160 min. 
Urine was collected during and immediately after the experiments and analyzed 
for the content of sodium, potassium, and glucose.
During all human studies, routine monitoring comprised pulse oximetry and non­
invasive blood pressure. Patients undergoing surgery were also monitored with 
electrocardiography.
8.4 Calculations
Oxygen delivery and consumption
Brain and whole body oxygen delivery and consumption were calculated in paper 
1 from the measures of cardiac output and the arterial oxygen content (CaO2) were 
used to calculate the oxygen delivery (DO2) and oxygen consumption (VO2) as 
follows [177]:
CaO2 = 1.34 * B­Hgbn * SaO2 + (0.223 * PaO2)
DO2 = cardiac output * CaO2/BW
VO2 = cardiac output * (CaO2 ­ CvO2)/BW
where the arterial oxygen tension is expressed in kilopascals (kPa) and B­Hgb in 
g/L of whole blood. To calculate DO2 and VO2 for the brain, the input data con­
sisted in the carotic blood flow rate and the blood gas analyses (SaO2 and PaO2) 
obtained from the samples taken from arterial blood and from the cephalic part 
of the external jugular vein.
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Fluid and glucose distribution
For the distribution of irrigant water, as calculated in paper 1, the baseline blood 
volume was taken to 7% of the body weight and subsequent changes were estimated 
from the dilution of the B­Hgb concentration with corrections for the amount of 
withdrawn blood [178]. Since sodium ions (Na) are distributed throughout the 
extracellular fluid (ECF) space, the serum sodium concentration during or after 
infusion of fluid (S­Nat) at any time t equals the amount of Na in the ECF volume 
divided by the current ECF volume. Hence,
where S­Na0 and ECF0 are the serum sodium concentration and ECF volume at 
baseline, respectively, Naloss is the natriuresis (in mmol), and ∆ICF is the change in 
the water content of the intracellular fluid compartment. Since ECF0 corresponds 
to 20% of the body weight, ∆ICF could be calculated by rearrangement of the 
equation shown above.
The kinetics of the glucose infusion in paper 4 was studied to characterize how 
effectively the volunteers handled the glucose molecules and the accompanying 
water volume. Hence, the pharmacokinetics was analyzed using a one­compartment 
turnover model in which the plasma concentration of glucose above baseline (C) 
at any time (t) resulting from the infusion rate ki is calculated by using the fol­
lowing differential equation:
where Vd is the volume of distribution and CL is the glucose clearance [169].
For the fluid volume, a one­volume kinetic model was used in which fluid infused 
at a rate ki expands a central body fluid space v, which strives to return to its base­
line volume V by two mechanisms: first, elimination of fluid at a rate proportional 
by a constant kr to the dilution of V, i.e., the rate of elimination at any time was 
kr (v – V)/V and, second, a baseline loss (kb) fixed to 0.5 mL/min to account for 
evaporation and basal diuresis, which occurs at a rate of approximately 700 mL/d 
in adults [179]. Thus, the parameter kr is a clearance constant.
The volume change in the central body fluid space (v) was then expressed as:
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The dilution of the plasma was calculated based on the blood chemistry obtained at 
baseline (time 0) and at any later time (t). The principle is to convert hemodilution 
into plasma dilution based on the average of the Hgb and RBC dilutions because 
these are measured by different laboratory methods (photometry and laser beam 
dispersion, respectively). Hence, 
Before use, this expression was corrected for “iatrogenic” dilution resulting from 
the sampling (7 mL per sample) and also by the ratio MCV0/MCV(t) to account 
for changes in erythrocyte cell size [179]. The best estimates and the associated 
standard deviation for the unknown parameters in these models, being Vd and CL 
for exogenous glucose and V and kr for the infused fluid volume, were estimated 
for each of the 10 experiments individually by applying a nonlinear least squares 
regression routine based on a Gauss­Newton method to the analytical solutions 
of equations. 1 and 2 until no parameter changed by more than 0.0001 (0.01%) in 
each iteration [169, 179­180]. 
Predictions of the plasma glucose concentration over time for various theoretical 
infusion regimens were obtained by inserting the best estimates of Vd and CL for 
the group into the mathematical solution to Equation. 1, using the same computer 
program (Matlab version 4.2, Math Works, Natick, MA) as the one used for analysis. 
Simulations included 60­min plots of early (first 30 min), late (last 30 min), and 
continuous absorption patterns. Volumes of up to 2000 mL were tested in steps of 
250 mL for every possible combination of early, late, and continuous absorption. 
A nomogram was constructed based on the observation that the postsimulation 
glucose level decreased approximately 30% per 10 min.
Nitrous oxide
In order to get N2O measures, in part per million (PPM), representative of exhaled 
air, the output samples in papers 2 and 3 were adjusted for CO2 levels to account 
for different breathing patterns and admixture with ambient air. Several ways of 
minimizing the variability in N2O were tested and compared based on the data from 
the continuous infusions in study 2 and we arrived at the following approach. For 
the end of each 5 min interval of these 12 experiments, the individual area under 
the concentration curve (AUC) for N2O was calculated by the linear trapezoid 
method and based on the samples in which the CO2 was above the median value. 
The reason for discarding all values associated with a low CO2 concentration was 
to ensure that only the most representative data for exhalation were included. This 
AUC for N2O was then divided by the median CO2 for the remaining sampling 
points. This algorithm was then applied in all 120 experiments of paper 2, and 
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its ability to predict the infused fluid volume evaluated by residual plots for each 
series. To make the low­ and high­concentration experiments in paper 2 com­
parable, fluid volumes used in the latter were too low and therefore multiplied by 
2.5 to compensate for the difference in N2O content between infusions. In paper 3 
the individual AUC for the breath N2O in each patient was calculated in the same 
fashion but for every second. The data on breath N2O were then transformed into 
the volume of irrigant absorbed by applying the following regression equation, 
which was derived from the infusion experiments in paper 2:
As N2O is eliminated quickly from the body, the N2O integral summarized all 
absorption events occurring during the operation.
Ethanol
For the ethanol monitoring method, the absorbed volume per 10 min was calculated 
using the following empirical equation derived during TURP [108]:
where Volumeabs is the predicted incremental volume of absorbed fluid (ml) 
Ethanol is the blood ethanol concentration (mg/ml) as indicated in the breath in 
the beginning of a 10-min interval, and ΔEthanol is the change in this concentra­
tion during the same 10­min interval. The ethanol equation is governed mainly 
by the distribution function of ethanol in the total body water while elimination 
of the tracer is quite slow. 
8.5 Statistics
Overall, data were normally distributed and expressed as the median or mean with 
standard deviation (papers 2–4) or standard error of the mean (paper 1).
Differences between sampling sites in paper 2 and between groups as well as 
changes from baseline in paper 1 were studied by repeated­measures ANOVA. For 
the changes from baseline this was then followed by Dunnett’s test. For paper 1 
the repeated­measures ANOVA was specified for the time frame of each analy­
sis, i.e. during infusion, the post infusion period and over the entire experiment. 
Linear regression was used for analyzing the correlations between parameters in 
papers 1, between absorbed volume and N2O and ethanol concentration in paper 2 
and between sodium and glucose changes in the clinical part of paper 4. In paper 2, 
an algorithm was developed, from the 12 continuous infusion experiments, for the 
prediction of absorbed volume based on the exhaled air concentrations of N2O. 
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The validity of the algorithm was then tested on all the infusion experiments by 
investigation of the obtained scattering of the residual plots when fitting a linear 
regression equation to this relationship.
The 95% prediction interval was used for estimation of absorbed volume from 
breath samples of N2O and ethanol in papers 2 and 3. The agreement between the 
two methods in paper 3 was illustrated by Bland­Altman plots. 
In paper 2, the coefficient of variation (CV) for breath N2O was obtained as SD 
divided by the mean over time. CV was recalculated every 30 s, and the Wilcoxon 
test was used to compare results between continuous and intermittent infusions.
P < 0.05 was considered significant.
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9 ETHICAL CONSIDERATIONS
The study protocols for all studies were approved by the regional ethics committees 
in Stockholm and all volunteers and patients gave their written informed consent. 
The reference numbers for these approvals are as follows:
1) Paper 1: Stockholm southern animal ethics committee, S66­97
2) Paper 2: Research ethics committee south, Huddinge Hospital, 267/02
3) Paper 3: Research ethics committee south, Huddinge Hospital, 76/03
4) Paper 4: Regional ethics committee, Stockholm, 2007/851­31/4
The known dangers involved in administering high volumes of electrolyte­free 
irrigating fluids in paper 1 did not allow for this research to be carried out on human 
subjects. A model with relevant physiology and size as compared to humans was 
needed in order to be able to study the organ specific and whole body pathophysi­
ology in a meaningful way. The pigs were taken care of by professional animal 
keepers and were acclimatized in a nearby sty to where the study was conducted. 
Premedication was given in advance to the experiments and the level of mainte­
nance anesthesia was repeatedly checked. The animals were killed at the end of 
the investigations and while still under general anesthesia.
The volunteers in papers 2 and 4 had a routine health check­up including laboratory 
screening of liver function tests, creatinine, sodium, potassium and glucose levels 
prior to their participation in the respective study. They received two venous can­
nulas by either a certified nurse or a doctor. This may involve short transient pain 
but no other adverse reactions occurred. The sampled blood volume was less than 
100 ml in all subjects. The infusion regimens with mannitol 3% and ethanol 1% 
in paper 2 had been used in several previous studies without any adverse effects 
except maybe slight sensation of being tired which could have been due to that the 
subjects in those studies were completely fastening. Our subjects were allowed a 
light breakfast before experiments. The volunteers in paper 2 were asked about the 
comfort of the various N2O­sampling methods tested and this played a significant 
role in the future choice of using a flared nasal cannula.
The patients all followed hospital routines which included the ethanol method in 
paper 3 and the analysis of pre­ and postoperative blood chemistry in study 4. The 
flared nasal cannula used for N2O sampling in study 3 was the hospital standard 
procedure for delivering supplementary oxygen to all patients undergoing spinal 
anesthesia. In addition, paper 3 was done according to GCP guidelines and an 
external review board was used for the monitoring of adverse events.
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10 RESULTS
The findings with regards to the pathophysiological alterations seen with all irri gating 
fluids in paper 1 were that blood volume, cardiac output, ICP, mean  pulmonary artery 
pressure, the carotic and aortic blood flow rates increased significantly during the 
infusions while the heart rate decreased by ≈ 20% (P < 0.001) and oxygen delivery 
to the brain increased transiently (P < 0.005). The latter was more consistent in 
the mannitol 5% group. The parameters showing the most pronounced increase 
in response to the infusions were the intracranial and pulmonary artery pressures 
and the blood volume. As the infusions ended, the whole body circulation became 
hypokinetic. 30 min later, cardiac output and aortic blood flow had dropped to 
approximately 50% of the baseline, and mean arterial pressure to about 80% 
(P < 0.02) while brain blood flow rates were maintained. There were no changes 
in pH or base excess in jugular venous blood. Signs of interstitial heart dilatation 
were found in all groups except the controls although no significant changes in 
the serum activities of creatine phosphokinase and troponin T were seen. The 
heart rate corrected QT time increased by 15–20% during both glycine 1.5% and 
mannitol 5% infusions (P < 0.03). The B­Hgb and serum sodium concentrations 
decreased markedly during both these infusions and the urinary excretion rate 
and the natriuresis increased progressively (P < 0.001). At the end of the experi­
ments, 41, 46% and 30% (mean) of the infused volume of the glycine, mannitol 
5% respectively mannitol 3% solutions had been recovered in the urine. 
As for the differences between glycine 1.5% and mannitol 5% the peripheral 
vascular resistance decreased and the blood volume increased most during the 
mannitol infusions (P < 0.001). The pulmonary artery pressures increased most in 
response to glycine 1.5%. Serum sodium decreased more (from 140 to 98 mmol/L 
at 80 min) when mannitol was given (P < 0.002) as compared to glycine (from 136 
to 103 mmol/L at 80 min) but the serum osmolality still only decreased (from 292 
to 277.3 mosm/kg) in the glycine group (P < 0.002). In spite of increased kaliuresis 
occurring only in response to glycine (P < 0.001), the serum potassium concentra­
tion increased from 3.6 to 4.4 mmol/L while it decreased from 3.5 to 3.3 mmol/L 
during the mannitol infusions. The change in intravascular volume was significantly 
larger for mannitol during the first 30 min of the infusions (P < 0.05). Glycine 
increased the intracellular fluid volume (ICV) more than mannitol did (P < 0.002). 
After the infusions, the interstitial fluid volume was larger with mannitol (P < 0.03). 
The difference in urinary excretion did not quite reach statistical significance. The 
whole­body oxygen delivery decreased significantly in the glycine experiments 
(P < 0.04) and the oxygen consumption also tended to decrease (P = 0.12) while 
both these parameters remained unchanged during the mannitol infusions. A slight 
base deficit developed in arterial and mixed venous blood (P < 0.001), in particular 
when mannitol was infused but pH remained within the normal range. 15 min in 
to the experiments and onward, ICP was significantly higher in the animals given 
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glycine and after the infusions, the intracranial pressure remained high only in 
this group (P < 0.001 when compared to baseline). Oxygen consumption in the 
brain decreased progressively to about 50% of baseline in response to mannitol 
(P < 0.001), while it was more variable and did not change significantly in the 
glycine group.
Cardiac morphology and conductivity also differed between the irrigating fluids. 
The highest scores for leakage of myoglobin, focal necrosis, and rupture of the 
histoskeleton were obtained for glycine 1.5%, whereas mannitol 5% had inter­
mediate and mannitol 3% the lowest scores. There were significant linear cor­
relations between myoglobin leakage, focal necrosis (P < 0.02), and rupture of 
the histoskeleton (P < 0.006), whereas interstitial dilatation correlated only with 
rupture of the histoskeleton (P < 0.04). Nearly all observed changes occurred both 
in the subendocardium and deeper in the myocardium. Mannitol 5% significantly 
increased the PQ time (+20%, P < 0.05 versus glycine) and decreased the QRS 
amplitude (­20%), while glycine tended to prolong the QRS duration (+25%) and 
increase the T­wave amplitude (+50%).
As for mannitol 3%, a slightly smaller increase in intracranial pressure than the in 
glycine pigs was seen (mean 140 versus 170% of baseline, respectively, at 90 min, 
a nonsignificant difference) but a larger one than in the pigs given mannitol 5% 
(mean 28%, P < 0.01). The changes in heart rate and in the serum sodium (from 138 
to 100 mmol/L at 80 min) and potassium concentrations (from 4.0 to 4.1 mmol/L) 
were similar to those for isotonic mannitol, while the serum osmolality decreased 
from 292.8 to 278.5 mosm/kg, following the glycine curve. The ICV increase was 
between 7 and 10% less for mannitol 3% than for the glycine.
Even though correct placement of the intracranial catheter was verified by X­ray 
examination with contrast medium, the two control pigs showed a slight sponta­
neous increase in ICP from 7 to 10 mm Hg respectively from 2 to 4 mm Hg over 
a 110­min observation period.
For the nitrous oxide measurements in paper 2 and 3 no adverse monitoring related 
events occurred. In the comparison of sampling sites, there were fairly small but 
still statistically significant differences in the CO2­adjusted AUC for the N2O con­
centration depending on whether sampling was done from a flared nasal cannula 
(reference), a standard nasal cannula (+14%) or a Hudson mask (+8%). Adding 
O2 via a flared nasal catheter marginally changed the AUC obtained via any of 
these airway devices. In contrast, end­expiratory sampling yielded a 25% lower 
value (P < 0.001). All volunteers agreed that the flared nasal cannula was the most 
comfortable sampling method. The individual N2O time–concentration profiles had 
a different appearance depending on the mode of infusion showing quite variable 
patterns with bursts in the N2O concentrations for the three intermittent infusions 
while in the patterns gradually increased towards a steady state for the continuous 
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infusions. Mathematically this was also shown as the CV for the N2O concentra­
tion over 3­min intervals was much higher for the intermittent than the continu­
ous infusions (mean 0.70 vs 0.26, P < 0.001). The 3­min interval was the shortest 
that still offered an excellent distinction between the two types of infusions. The 
CO2­adjusted AUC for N2O did not differ significantly when the fluid volume in 
the high­dose experiment was multiplied by 2.5, i.e. the factor with which the N2O 
concentration differed between low­ and high­dose experiments. For all infusions, 
the AUC strongly correlated with the volume of infused N2O­containing irrigating 
fluid, regardless of whether the fluid was infused continuously or intermittently 
with a high or low N2O concentration. The 95% prediction interval was ± 200 ml, 
and overall the data showed a normal distribution, when plotting the residuals, 
around the regression line. Blood Hgb and serum sodium concentrations decreased 
by 6% during the continuous­infusion experiments (repeated­measures ANOVA, 
P < 0.001), but only Hgb was restored during the follow­up period.
Breath ethanol concentrations obtained during the continuous and intermittent 
infusions of irrigating fluid in paper 2 slightly overestimated the known infused 
fluid volume. The 95% prediction interval was approximately 400 ml which is in 
agreement with previous findings based on a larger number of data points. In the 
clinical paper 3, thirteen patients (15%) absorbed > 300 ml of fluid as indicated by 
the control method (ethanol). The median volume was 707 ml (range 367–1422). 
The time period during which there was absorption during these 13 operations 
was 40 min (15–90), while the operating time was 65 (50–124 min), i.e. absorp­
tion occurred during 58% (22–100) of the period of surgery.
In comparison of the ethanol and the N2O method in paper 3, the amount of irri­
gant absorbed was correlated at the end of each 10­min period of surgery during 
which the ethanol method indicated the presence of absorption (ethanol concen­
tration > 0). The ethanol yielded higher figures for fluid absorption up to about 
700–800 ml where after the N2O method indicated that the absorption was larger. 
Over the entire range, however, the mean difference between the ethanol and N2O 
methods was +45 ml (95% limits of agreement, –479 to +569 ml). When only the 
last measurements during each operation were compared, the mean difference 
was – 133 ml (95% limits of agreement, –833 to +587 ml). In 33 patients, the 
N2O method indicated small or modest degree fluid absorption, while the etha­
nol method indicated no absorption. All these cases occurred at centre 2 and is 
explained by the fact that that ethanol concentrations of 0.04 mg/ml or less were 
displayed as zero by the alcolmeter used. In the evaluable patients, we found no 
clear evidence of N2O being absorbed through the intact bladder.
The most frequent concomitant diseases, in paper 3, were hypertension, 29; angina 
pectoris, 7; asthma, 3; atrial fibrillation, 2; cerebrovascular accident, 4; and dia­
betes mellitus, 4. Thirteen patients experienced at least one serious adverse event. 
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These included haematuria, 5; intraoperative haemorrhage, 1; fever, 1; duodenal 
ulcer, 1; and syncope, 1.
In the clinical part of paper 4, there was a statistically significant linear relationship 
showing that each mmol/L decrease in serum sodium concentration increased the 
serum glucose by 1.5 mmol/L when 5% glucose in water was used as the irri gating 
solution. For nondiabetic and diabetic patients, respectively, the coefficients of 
determination were 0.80 (P < 0.0001) and 0.92 (P < 0.0001). Those patients who 
received 1.5% glycine but did not absorb the irrigating fluid, as evidenced by a 
change in serum sodium by no more than 1 mmol/L, had no significant change 
in serum glucose during monopolar TURP (mean 0.05 mmol/L, SD 0.65). The 
incidence of TUR­syndrome in 233 of the patients where symptoms could be 
determined was 2.1%, (95% CI 0.7–5.0) with an average absorbed volume of 
absorption of 3.6 (2.6–4.1) L as calculated by the degree of sodium dilution. All 
the background data on these patients have been reported elsewhere [181].
Plasma glucose almost doubled during the experimental infusions and reached 
a maximum of 8.27 mmol/L (SD 0.95), while the plasma was diluted by 17.7% 
(3.2%). The excreted urine at the end of the experiments (160 min) had a  volume 
of 1.14 (0.77) L, which represented 66% (37%) of the infused fluid volume. 
During the infusions, the changes in serum sodium from 140.7 mmol/L (SD 1.5) 
to 138.8 (2.0) and potassium from 3.87 mmol/L (0.22) to 3.99 (0.22) were not 
significant. The total urinary excretions were 89.4 mmol/L (SD 35.4) for sodium 
and 22.8 mmol/L (10.4) for potassium. At the end of experiments, serum sodium 
was 140.3 mmol/L (SD 2.0) and potassium 4.05 mmol/L (0.21). No glucosuria was 
found. The hemodynamic variables changed mainly at the beginning of the infusion, 
averaging +9% for the systolic pressure, +12% for the diastolic pressure, and –7% 
in heart rate. No adverse reactions were seen during the experimental infusions.
For exogenous glucose, the kinetic analyses of the simulations showed that Vd 
amounted to 15.52 L (SD 2.15) and CL to 0.56 L/min (0.15). For the infused water 
volume, the expandable body fluid space was 6.03 L (2.70) and kr 0.19 L/min 
(0.12). A nomogram was successfully constructed and showed that, regardless of the 
simulated pattern of fluid absorption over 1 h, the uptake of 2 L of irrigating fluid 
containing 1% glucose would have increased plasma glucose by 6.9 (1.7) mmol/L 
at the end of the surgery. The corresponding increase for 1 L of irrigating fluid was 
3.7 (1.6) mmol/L.
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11 DISCUSSION
In the clinical study (paper 3), 15% of the patients absorbed > 300 ml of fluid as 
indicated by the ethanol method. The median volume absorbed was about 700 ml 
over 40 min of the average operating time of 65 min. In the clinical part of paper 4, 
2.1% were diagnosed with the TUR­syndrome. These data are in agreement with 
other studies in TURP patients [29­30].
All fluids (glycine 1.5%, mannitol 3%, mannitol 5% and RS with 1% glucose) 
administered in papers 1 and 4 yielded a swift response in hemodynamics with an 
increase in blood pressure and a decrease in heart rate within 15 min. The hemo­
dynamic variables in the volunteers had returned to baseline at about 30 min after 
the RS­infusion was discontinued and remained so for the rest of the observation 
period although the subjects were still slightly overhydrated. In contrast, the flow 
rates fell promptly when the infusion of the electrolyte­free irrigants was stopped 
and a low­flow state developed despite the marked overhydration of the animals. 
The cardiac output and the aortic blood flow rate had fallen to about 50% of baseline 
30 min after these infusions, while the carotic blood flow was upheld. This hypo­
kinetic circulation corresponded to intravascular hypovolemia. Low cardiac output, 
hypotension and hypovolemia has also been seen in clinical studies exploring the 
TUR­syndrome. [54, 182­183]. The arterial hypotension of sudden onset appear­
ing 30–60 min after surgery is, along with nausea, the most prominent symptom 
of moderate­sized glycine absorption [53]. The hypovolemia develops in response 
to water and sodium losses from osmotic diuresis. Mannitol is not reabsorbed 
in the kidneys and glycine overwhelms [184­185] the reabsorptive mechanisms 
for amino acids [80]. The decrease in plasma sodium concentrations promotes 
 cellular edema even when the iso­osmotic mannitol 5% is given. Glycine is also 
taken up by active transport into the cells and it then brings along fluid by virtue 
of osmosis [186]. Hyperkalemia and kaliuresis was seen in the glycine pigs. This 
is likely due to the more pronounced intracellular edema which causes the cells 
to pump out potassium as a means of restoring their volume [187]. The 20 min 
infusion of 15 ml/kg of mannitol 3% and ethanol 1% rendered a 6% decrease in 
Hgb and serum sodium levels in the volunteers in paper 2. Hgb but not sodium 
concentrations returned to baseline during the post­infusion observation period. 
Hence, sodium losses were apparent here as well.
The fluid shifts can cause cerebral edema due to water intoxication which is 
thought to be the main reason for nausea, depressed consciousness and late death 
in the TUR syndrome [28, 100, 188]. We found a more pronounced increase in 
intracranial pressure for glycine 1.5% which reflects its stronger tendency to 
cause cellular edema. Mannitol 3%, which had a similar osmolality, produced 
slightly lower values. Mannitol 5% was associated with the smallest changes in 
intracranial pressure.
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Ringer’s solution is also slightly hypo­osmotic which could promote cellular 
edema but the natriuresis in response to Ringer’s solution is smaller than the 
water excretion [189]. In paper 4, the excreted amount of sodium was 89 mmol, 
while 205 mmol had been infused (Ringer’s solution contains 130 mmol/L). As 
the serum sodium concentration was virtually the same at end of the study as 
before it started, simple mass balance calculations [189] indicate that the retained 
sodium must have bound more water than the retained 400 mL of infused fluid 
in the extracellular fluid space, and this volume can only have been derived from 
the intracellular fluid space. Hence, there is no evidence that Ringer’s solution 
with 1% glucose caused intracellular edema but rather that the opposite was the 
case. Absorption of electrolyte containing irrigating fluids still poses a potential 
problem with volume overload even though hyponatremia and its consequences 
with brain edema is prevented. Rapid vascular overload can cause symptoms of 
swelling, dyspnea and a risk of fatal pulmonary edema [190­192]. Furthermore, 
absorption of isotonic saline, as compared to RS, is likely to increase mortality 
and the risk of major adverse kidney events [22­23].
Fluid overload also causes a strain on the heart. In the animal experiments, the 
most pronounced myocardial damage was seen with glycine 1.5% followed by 
mannitol 5%. The glycine effects are probably due to cellular edema while the 
iso­osmolar mannitol 3% may cause less intravascular fluid overload and thus less 
myocardial strain than mannitol 5%. In addition, the infusions caused prolonged 
QTc interval which can be explained by the consistent hypocalcemia that was seen 
[43]. Bradycardia, prolonged PQ interval and a glycine specific increase in QRS 
duration were also seen. Previous studies have found similar disturbances [12­13].
Two novel approaches to diagnose irrigating fluid absorption were introduced in 
this thesis. The idea was that measurements of an added tracer amount of either 
N2O or glucose to the irrigant would correlate with the volume absorbed. A pre­
requisite for these correlations is that the uptake of these tracers only occurs in 
response and proportion to fluid absorption. Unpublished data in pigs before the 
start of study 2 and 3 showed that the urinary tract epithelium is impermeable to 
N2O. In the clinical investigations of papers 3 and 4 we validated that the meas­
ured levels of N2O respectively glucose only increased in response to absorption. 
The exhaled air concentrations of N2O and CO2 during spontaneous breathing 
were measured in response to iv infusions to which either 40 ml/L or 100 ml/L of 
N2O had been added. The N2O concentration of 100 ml/L in the infusion did not 
offer any advantages in respect to accurate predictions of the pattern or volume of 
infusion. A higher N2O concentration is also inferior in regards to environmental 
considerations and especially the theoretical risk of accumulation of explosive gas 
mixtures during electroresection [195­196]. A 4% solution of N2O in combination 
with flammable gases does not produce any such explosive mixtures [175]. Hence, 
the 4% concentration was used in all other experiments.
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An algorithm was developed based on 12 of the 120 infusion experiments, and 
eventually validated in all of them by demonstrating limited scattering on residual 
plots. This algorithm adjusted the N2O data with regard to the depth of breathing 
and also removed measurements performed during apparent inhalation. Since 
the AUC for a drug changes in proportion to the dose, we finally used the CO2­
corrected AUC for N2O concentration as the expression for infused fluid volume. 
The obtained correlations were slightly influenced by the sampling method and 
simultaneous oxygen delivery only marginally affected the results. We concluded 
that further experiments should be performed using a flared nasal cannula, rather 
than standard nasal cannula or Hudson mask, since it was preferred by the volunteers. 
End­expiratory sampling yielded lower values than the three modes of continuous 
measurement. This might be explained by the fact that the measuring chamber for 
N2O is larger than that for CO2. The N2O chamber then partially equilibrates the 
concentration over time which yields a falsely low peak at the end of exhalation. 
The volunteers also had difficulty in providing a forced end expiratory sample 
every 30 s, which probably made this mode of measuring less accurate.
There was a linear correlation between the infused volume and both the N2O 
concentration and ethanol algorithms. In our infusion study, the N2O method was 
more precise than the ethanol method with a 95% prediction interval of ± 200 ml 
respectively ± 400 ml for any new volume estimate. The wider prediction inter­
val of ethanol was based on fewer observations but is in agreement with the 90% 
prediction interval of ± 300 ml obtained for 160 TURPs [107]. 
Clinical comparison between N2O and ethanol in paper 4, showed that the scatter 
between the ethanol and N2O methods was about twice as high as between the N2O 
algorithm and known amounts of fluid in the volunteer study. The difference in 
the predictions of fluid absorption was clearly dependent on the absorbed  volume. 
In addition, we found the same agreement between the methods even when the 
last step of the algorithm, which divides the N2O AUC by the CO2 median, was 
omitted. This may be due to that this step primarily compensates for differences 
between sampling devices and that only the flared nasal cannula was used in the 
clinical study.
We predicted the fluid absorption by an equation based on ethanol data, obtained 
every 10 min, in a series of 90 TURP patients in whom the control method was 
careful measurements of the volumetric fluid balance and serum sodium [108]. The 
mean deviation between predicted and measured fluid absorption was claimed to 
be 19%. A dose­dependent bias between the ethanol method and known amounts 
of infused fluid, which has similarities to the pattern of agreement between N2O 
and ethanol in paper 3, has previously been seen in volunteers [197]. Up to 800 ml of 
fluid, the ethanol method overestimated the absorbed volume by on average 200 ml, 
while larger volumes were underestimated. This pattern seems to be expected when 
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the fluid administration is continuous, while fluid absorption during surgery most 
often occurs in a more haphazard, intermittent manner [10]. Naturally, the bias is 
larger when N2O indicated absorption is compared with the ethanol method than 
with more precisely known amounts of volume. In retrospect, additional tools 
for estimating fluid absorption might have given a better evaluation of the N2O 
method. In paper 2, where the amount of administered fluid was actually known, 
the N2O method was clearly the more precise of the two. Still, both methods were 
quite helpful to the surgical staff by early signaling ongoing fluid absorption. Both 
offer a possibility to stop further absorption by reducing the fluid pressure and/
or the extent of surgery. Treatment can be started early and the optimal level of 
post­operative care can be chosen [107]. 
There are also several clinical advantages of the N2O method as compared to the 
ethanol method. In fluid absorption, ethanol concentrations may increase to  levels 
that causes a slight inebriation and makes car driving illegal. There may also be 
issues with ethanol use in certain religions and patients with liver impairment. 
The concentrations of N2O reached in our studies were in the range of 0–300 ppm 
and thus within the environmental pollution range. Pharmacological effects of 
N2O occurs at a concentration around 15% or higher, which is about 500 times 
higher than the maximum concentrations measured in our experiments. In addi­
tion, N2O is highly inert with a quick elimination during the first passage over the 
lungs. This further lowers the exposure to the patient’s central nervous system and 
probably makes any potential accumulation of gas in the intestines unimportant. 
Exhaled N2O is also quickly diluted in the ambient air, and any elevated concen­
tration soon becomes impossible to detect. The rapid elimination of N2O makes 
distinction between extravasation and intravascular absorption easier than with the 
ethanol method where elimination is much slower [107]. In the volunteer study 
in paper 2, the pattern of N2O concentrations in exhaled air differed considerably 
between continuous and intermittent infusions. This was also mathematically 
shown as the coefficient of variation, over each three­minute period, was clearly 
larger during the intermittent than the continuous infusions. Although not tested 
in our studies, extravasation results in N2O, ethanol and serum sodium responses 
that are only one­third of those found after intravascular absorption [107, 175]. 
Dangerous symptoms may develop before treatment is started if extravasation is 
mistaken for intravascular absorption [198]. The end­expiratory breath tests used 
in spontaneously breathing patients is another downside of the ethanol method 
since this may cause the patient to move and disturb the surgical procedure. In 
contrast, N2O can be monitored continuously without active involvement of the 
anesthetist, the surgeon or the patient.
The addition of glucose 1% to the irrigating solution has a different approach 
for its diagnostical purpose. The N2O and ethanol methods can be used for early 
detection of absorption and thereby alert the surgical and anesthetic team to initiate 
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adequate measures. In contrast, addition of glucose as a tracer is used for refuting 
or validating suspected absorption when indicated by clinical signs or symptoms. 
For electrolyte­free solutions this can be done by nomograms which correlate the 
degree of sodium­dilution to the absorbed volume. In the clinical part of paper 4, 
we found that absorption of an irrigating fluid consisting of isotonic glucose  during 
TURP increases the serum glucose concentration in an inverse linear proportion 
to the reduction in serum sodium. We conducted experiments in volunteers and 
kinetic simulations to assess the potential usefulness of glucose as a tracer when 
electrolyte­ containing irrigants are used, i.e. during bipolar TURP, which prevents 
the detection of sodium dilution. The volume of distribution and clearance of RS 
with 1% glucose was calculated in 10 healthy volunteers and, based on these data, 
various absorption patterns were tested in volume steps of 250 ml. The simula­
tions indicated that, regardless of the pattern of absorption during a 1­h operation, 
absorption of 1 and 2 L would increase the plasma glucose concentration by 3.7 
and 6.9 mmol/L, respectively, followed by a decrease of 30% per 10 min. The 
usefulness of glucose to detect fluid absorption can be judged only after consider­
ing the spontaneous variation of plasma glucose during TURP. The clinical trial 
showed that no consistent change in the glucose level occurs during TURP with 
no fluid absorption, not even in diabetics. This can be understood from the minor 
endocrine response associated with this operation [199]. The kinetic method used 
to analyze the disposal of glucose is independent of the infused amount and infu­
sion rate of glucose [169]. The clearance of glucose, 0.56 L/min, was similar to 
that found in previous volunteer experiments [169]. The kinetics of the infused 
fluid volume was analyzed according to a one­volume fluid space model, which 
is appropriate when elimination of the fluid is prompt [179]. In an individual 
patient, spontaneous variations may alter glucose levels. Our data indicated that 
the existence of absorption can be detected with 95% confidence if the plasma 
glucose concentration increases by more than 1.4 mmol/L even when consider­
ing such interindividual variations. As previously described, although absorption 
of electrolyte­containing solutions does not cause the problems associated with 
hyponatremia, the effects may still be severe. Absorption may be just as frequent 
and our study indicates that glucose can be a useful tracer to easily control for the 
suspicion of such irrigating fluid absorption.
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12 CONCLUSIONS
The N2O technique could serve as a clinical monitoring tool when administration 
of fluid may occur spontaneously in unknown volumes, such as fluid absorption 
during endoscopic surgery. Compared to available methods it is likely to offer the 
following advantages:
1) Immediate detection of amount and route of fluid absorption without active 
involvement of the patient or operating team.
2) Similar or better prediction of the absorbed volume than the commonly used 
ethanol method. 
3) The linear correlation between accumulated exhaled N2O concentrations and 
known amounts of infused fluid does not seem to be volume dependent.
4) The monitoring method does not affect the patient’s condition and is not 
restricted by religious limitations or by concomitant liver disease.
For optimal safety, patient comfort and the best prediction of the absorbed fluid 
volume, we propose using a N2O tracer concentration of 40 ml/L and collecting 
samples via a flared nasal cannula.
The use of an electrolyte­containing solution with 1% glucose for bladder irrigation 
during bipolar TURP is likely to detect clinically significant fluid absorption ( > 1 L) 
by measuring plasma glucose at least within the first 30 min of the postoperative 
period. This correlation seems not affected by the infusion pattern.
The fluid distribution, as seen in paper 1, showed that massive infusion of non­
electrolyte containing irrigants renders a hypovolemic hypokinetic state. Based 
on this, we propose the infusion of hypertonic saline to be the first line treatment 
when such absorption occurs.
Glycine 1.5 was associated with the greatest intracellular swelling, the highest ICP 
increase and the most damage to the myocardium. Mannitol 3% caused a higher 
ICP increase than mannitol 5% but less myocardial strain. In regards of adverse 
reactions, our findings advocate that the irrigating solution glycine 1.5% is aban­
doned and that irrigation with mannitol 5% is preferable to mannitol 3% when an 
electrolyte­free solution is indicated.
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13 LIMITATIONS
Several limitations of our studies need to be acknowledged. Overall, the experimen­
tal studies included few subjects although the study regimens were quite extensive 
for each subject. In addition, studies in experimental animals and volunteers may 
not be fully representative of variables seen in a clinical context. This includes 
such factors as inter species differences, metabolic and endocrine stress response, 
preoperative status, bleeding, perioperative infusions and drugs, etc.
The use of N2O as a tracer for detecting fluid absorption precludes the use of 
N2O as an adjunct to general anesthesia. Furthermore, one must consider that the 
regression line describing the correlation between N2O and the actually infused 
fluid volume is valid only for the measuring chamber size of 30 ml and a suction 
rate of 300 ml/min. The slope is likely to be slightly different with other settings. 
After conclusion of our experiments, a laboratory study revealed that N2O escapes 
from plastic fluid bags at a rate of 5% per hour (unpublished data). Administering 
an exact amount of N2O to the irrigating solution just prior to use might also be 
cumbersome. For clinical use, we believe that the N2O should be added to the fluid 
immediately before use via a small gas bomb attached to a port on the irrigating 
system. Additionally, the fluid bags could be made less permeable to N2O diffu­
sion. This arrangement would also prevent the need for more types of factory­
made irrigating fluids. Further studies during actual surgical interventions are also 
needed to evaluate the correlating amount of absorption in various settings and 
with a practical low­cost N2O and CO2 analyzer.
N2O may accumulate in gas­filled cavities and diffuse over various barriers in the 
body which may affect the recordings. The low concentrations seen in our studies 
and the high first passage elimination over the lungs makes this unlikely to affect 
the measurements.
The use of glucose as a tracer precludes simultaneous administration of insulin 
or glucose. This is however rarely indicated in adult endoscopic surgery, even in 
most diabetics. The metabolic stress response is of particular importance when 
absorption is traced by glucose concentrations. Fluid absorption or major blood 
loss shows a metabolic stress response, which is not the case for TURP without 
these complications [199]. Insulin resistance might also be more common in the 
elderly. This means that the plasma glucose level would be increased slightly higher 
during a clinical TURP with fluid absorption than in our volunteer experiments. 
In the clinical part of paper 4, no apparent effect of diabetes mellitus was found 
on the degree of hyperglycemia induced by 5% glucose. This is probably due to 
the fact that fluid absorption usually occurs during the latter half or at the very 
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end of the surgery. This allows little time for differences in the half­life of glu­
cose to affect the plasma glucose level. However, the absorbed fluid volume is 
likely to be progressively more overestimated by our nomogram if sampling of 
plasma glucose is delayed after the end of TURP. We advise further evaluation of 
the glucose method in patients with different severity of diabetes before it can be 
recommended in this patient population. Another issue to consider is a surgical 
duration longer than 60 min, which is the maximum duration recommended by 
most urological surgeons. Continuous absorption throughout a TURP procedure 
is rare. For such events, however, simulations up to 90 min (instead of 60 min) 
showed that plasma glucose will still increase by > 1.4 mmol/L for practically all 
patterns of fluid absorption, although the absorbed volume will be less certain. 
In prolonged surgery, it might be prudent to measure plasma glucose at 60 min if 
there is any suspicion of fluid absorption.
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14 ADDITIONAL AND FUTURE RESEARCH
The studies in this thesis have shown that N2O and glucose are promising tracers 
for the early respectively postoperative detection of irrigating fluid absorption. 
Furthermore, the gradual development of the pathophysiology involved in mas­
sive absorption of common electrolyte­free irrigating fluids has been outlined. 
Still, this thesis only explores a small part of what can be done within this field.
Future research should include the incidence of irrigating fluid absorption and 
symptoms in large cohorts in order to establish the importance of monitoring such 
occurrences in modern practice. A clear consensus for the optimal electrolyte­free 
and electrolyte­containing irrigant is also still lacking and the role of buffered 
electrolyte­containing irrigants should be further investigated. The validity of the 
N2O and glucose methods needs to be validated in various patient groups, kinds of 
surgery and clinical contexts. Preferably, these results should be compared with as 
known volumes of absorption as possible. The optimal way of adding and measur­
ing N2O in irrigating solutions in a clinical context requires further exploration. 
Automated computerized algorithms would be helpful in clinical decision making.
In addition, N2O and other inert gases may serve as valuable tools for measuring 
other unknown local to whole body distributions. This may include the passage 
through potentially obstructed conduits and monitoring the blood supply in ischemic 
regions or parts of the body where this is a threat, i.e. skin flaps, peripheral arterial 
occlusive disease, reimplantation of digits, etc. 
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